Search Browse Earnings

Xencor Inc — SlamSEC

Xencor Inc

Nasdaq:XNCR

Pharmaceutical Preparations·PASADENA, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$174.6M

+6.1% YoY

FY 2025

Adj. EBITDA

-$120.9M

-69.2% margin

FY 2025

Net Income

-$133.1M

-76.2% margin

FY 2025

EPS (Diluted)

-$2.20

FY 2025

Stock Price

$12.04

+0.3%

2026-03-11

52W Range

$6.92 – $18.69

P/E Ratio

-5.5x

Market Cap

$883.0M

Cash

$40.9M

FY 2025

Total Debt

$163.6M

FY 2025

Net Debt

$122.7M

FY 2025

Enterprise Value

$1.0B

Debt / EBITDA

-1.0x

FY 2025

EV / EBITDA

-8.3x

Employees

—

CEO

Dahiyat Bassil I

CFO

Cornelissen Bart Jan